Skip to main content

Indian Funding:

  • Asia Healthcare Holdings (AHH), which operates Motherhood Hospitals and Nova Fertility Clinics, has struck a deal to pick up a majority stake in a urology and nephrology care-focused hospital chain.  The deal marks the foray of AHH, the healthcare platform of private equity firm TPG, into the fourth single specialty vertical after oncology, women and children’s care, and IVF and fertility.

Global Funding:

  • Leone Solutions Group (LSG), a global consulting and technology firm committed to advancing positive societal change, has raised $3.3M in pre-seed funding for their latest venture, CLEONA, an AI-driven tool designed to advance maternal healthcare. 
  • MedTech company GE HealthCare has been awarded a grant of more than $44M by the Bill & Melinda Gates Foundation. The funding will accelerate the development of AI-assisted ultrasound tools designed to improve healthcare outcomes in low-and-middle-income countries. 
  • Blooming Health, a digital engagement platform targeting older adults, has closed an oversubscribed seed funding round of $4.2M. The company aims to redefine aging-in-place by equipping community-based care providers with technology.

FemTech News:

  • A new research Bill and Melida Gates foundation revealed that, by making new innovations accessible to those who need them most, 2 million additional lives could be saved by 2030, and 6.4 million lives by 2040.
  • One in five women in the UK believe their employer does not offer enough menstruation and menopause support, a new report has found. The research found that almost a third of females surveyed shared that they only feel comfortable talking about menopause and menstruation with other female colleagues, with one in five women not feeling comfortable talking to anybody at all about it.
  • Millions of women and girls in the UK suffer from period problems, such as severe pain and heavy bleeding, with more than half reporting their symptoms not taken seriously, research has shown. A new survey has found almost a third of women and girls with period symptoms do not seek medical help for severe pain, heavy bleeding and other period symptoms. 
  • Recently surgeons have performed the first womb transplant on a woman in the UK, opening up the possibility for dozens of infertile women to have babies every year. 
  • A new study of medical devices for postpartum haemorrhage control was recently concluded. Postpartum haemorrhage is a severe vaginal bleeding that can occur within a day of giving birth or up to 12 weeks postpartum. The study revealed the effectiveness of an intrauterine vacuum-induced haemorrhage control device intended to provide control and treatment of abnormal PPH, a severe vaginal bleeding after childbirth that can occur within a day of giving birth or up to 12 weeks postpartum.
  • India’s largest period Health Study was carried out by FemTech India Partner company – Gynoveda. Some of the key highlights from the survey include:
  • 83% of women endure painful periods and only 17% face pain-free periods
  • 75% of women experienced irregular periods, often using few than 5 pads per cycle
  • PCOS affected 60% of women aged 24-34 and 51% of those under 24
  • PCOS related-issues were weight gain, facial hair, acne, and pigmentation.

FemTech India Partner Company News:

  • RocketHealth hosted a support group for the new cohort of Entrepreneur First, and discussed pointers on entrepreneurship, mental health, and solved worksheets together.
  • HempStreet has published a thought ware on “How can vijaya help you manage Alzheimer’s and Enhance Brain Health and Function”
  • Carina Kohli, founder Humm Care will be part of Power Hour- a talk series and the theme was “Understanding your relationship with food while working out”, to be held on 23 September, 2023

Global Companies:

  • The US virtual care platform Equip has expanded its eating disorder services to adults, in a move that could help millions access treatment. Equip is an online provider that aims to help people struggling with eating disorders through dedicated virtual care teams and at-home treatment.
  • Pharmaceutical giants Gedeon Richter and Sumitomo Pharma recently received a positive opinion for RYEQO. The drug, initially approved for the treatment of uterine fibroids, is on track to receive European Commission (EC) approval for the symptomatic treatment of endometriosis.
  • Natural Cycles, the FDA-cleared and CE-marked birth control app, announced today that it has received 510(k) clearance from the U.S Food and Drug Administration (FDA) as well as from European regulators for integration with Apple Watch Series 8 and Apple Watch Ultra.

Drugs, Diagnostics, and Pharma:

  • Samsung Biologics announced a new agreement with Bristol Myers Squibb for large-scale manufacturing of a Bristol Myers Squibb commercial antibody cancer drug substance. Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug and have expanded the strategic relationship over time
  • Aiosyn, a medical software company specializing in AI-powered pathology solutions, has announced the release of an AI kidney suite designed to advance research in the field of renal disease.

Government News:

  • Karnataka government has now inked a pact with the Centre for Cellular and Molecular Platforms (C-CAMP) to strengthen its public health settings through innovative and indigenous med-tech solutions. C-CAMP is part of the Department of Biotechnology of the Union government and has made several notable efforts in the area of deep-tech.
  • The National Pharmaceutical Pricing Authority (NPPA) has notified separate ceiling prices for antibiotic scheduled formulations Tazofic injection 2.25 gm and 4.5 gm packs from Mumbai-based Gufic Biosciences Ltd on account of special packaging in dual chamber bag.

Research, Insights, and Market Projections:

  • Ultra-processed food significantly raises the risk of high blood pressure, heart disease, heart attacks and strokes, according to two studies that one expert says should serve as a wake-up call for governments worldwide.
  • The Asian Pacific Society of Cardiology (APSC) recently published a report revealing that heart failure alone leads to 1.8 million hospitalisations each year in India. Prioritising heart health is of utmost importance for our overall well-being.
  • Significant strides made in genetics can now provide health insights that can empower individuals and healthcare providers to manage critical health conditions such as coronary artery disease (CAD)

Jobs on Board:

  • Newmi is looking for an Area Sales Manager. Newmi is India’s first omnichannel focused on women’s health and wellness.
  • Pee Safe is looking for a Growth Marketing Manager. Pee Safe is a wellness, menstrual, sexual hygiene expert whose was the key product Toilet Seat Sanitizer

Today’s newsletter is brought to you by Navneet Kaur and Jayant Pal Singh

Leave a Reply